🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The use of sodium glucose co-transporter 2 inhibitors (SGLT2i) has been ass...
Status
Completed
Location
L2 Diabetes Centre, Queen Mary Hospital
Start Date
2017-08-16
Trial ID
NCT03959501
Treatments Being Tested
The blood brain barrier (BBB) prevents some drugs from successfully reachin...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2023-06-05
Trial ID
NCT05762419
Treatments Being Tested
In recent years, diabetes has emerged as one of the most significant co-dis...
Status
Completed
Location
Children's Hospital of Philadelphia and University of Pennsylvania
Start Date
2013-06
Trial ID
NCT01879228
Treatments Being Tested
The purpose of this study is to examine the pre, post, and follow up effect...
Status
Completed
Location
Reno Orthopedic Center
Start Date
2020-11-30
Trial ID
NCT05058209
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
A clinical study to determine the safety, efficacy and the way sitagliptin ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-14
Trial ID
NCT00704132
Treatments Being Tested
The primary purpose of this study is to determine the safety and efficacy o...
Status
Unknown
Location
The Affiliated People's Hospital of Ningbo University
Start Date
2021-09-16
Trial ID
NCT05528887
Treatments Being Tested
The purpose of this study is to determine whether Etodalac, Etoricoxib and ...
Status
Unknown
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00793052
Treatments Being Tested
The discovery of FGF23, the missing link in the long researched and finally...
Status
Completed
Location
Chu Clermont Ferrand
Start Date
2021-10-05
Trial ID
NCT04846647
Treatments Being Tested
This randomized, double-blind, placebo-controlled trial will evaluate the i...
Status
Completed
Location
Center of New Medical Technologies
Start Date
2022-03-02
Trial ID
NCT06163443